
5.18BUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US83601L1026
CUSIP
83601L102
Sector
Healthcare
Industry
Diagnostics & Research
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
31.12
PEG Ratio
1.68
Book Value
2.33
Dividend Share
-
Dividend Yield
-
Earnings Share
0.57
Wall Street Target Price
22.61
EPS Estimate Current Year
0.98
EPS Estimate Next Year
1.08
EPS Estimate Current Quarter
0.2392
EPS Estimate Next Quarter
0.2707
Most Recent Quarter
-
Revenue TTM
1,216,173,056
Gross Profit TTM
668,513,024
EBITDA
576,577,984
Profit Margin
13.44%
Return On Assets TTM
8.60%
Return On Equity TTM
27.78%
Revenue Per Share TTM
4.271
Qtly Revenue Growth YOY
9.20%
Diluted Eps TTM
0.57
Qtly Earnings Growth YOY
569.50%
Trailing PE
31.12
Forward PE
17
Price Sales TTM
4.1627
Price Book MRQ
7.7812
Enterprise Value Revenue
5
Enterprise Value EBITDA
13
176.50
2.44%700.00
2.38%459.90
2.23%387.50
2.02%794.21
1.67%262.59
1.65%231.67
1.32%22.35
-3.50%669.85
-0.36%79.15
-0.20%